Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JANET PAN

NPI
1801056676
CMS profile
354136
Location
FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$5,339.64

303 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $5,288.29 299
Education $51.35 4

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $451.67 25
Merck Sharp & Dohme Corporation $353.23 18
E.R. Squibb & Sons, L.L.C. $335.81 28
Novartis Pharmaceuticals Corporation $316.08 17
Amgen Inc. $314.24 18
Eisai Inc. $276.19 14
Pharmacyclics LLC, An AbbVie Company $260.67 12
Bayer HealthCare Pharmaceuticals Inc. $230.44 15
Foundation Medicine, Inc. $214.89 5
Incyte Corporation $198.71 13
Janssen Biotech, Inc. $187.70 10
GlaxoSmithKline, LLC. $156.97 9
Seagen Inc. $153.75 8
Astellas Pharma US Inc $141.54 9
PFIZER INC. $139.07 11
Takeda Pharmaceuticals U.S.A., Inc. $118.87 6
AbbVie Inc. $116.49 7
Lilly USA, LLC $112.25 7
Coherus Biosciences Inc. $99.80 5
Exelixis Inc. $97.89 4
Kite Pharma, Inc. $92.56 6
Genentech USA, Inc. $72.28 4
Alexion Pharmaceuticals, Inc. $62.32 3
Teva Pharmaceuticals USA, Inc. $57.55 3
GENZYME CORPORATION $56.34 3
Boehringer Ingelheim Pharmaceuticals, Inc. $53.38 3
Daiichi Sankyo Inc. $51.77 4
Blueprint Medicines Corporation $50.57 2
Clovis Oncology, Inc. $49.48 2
Celgene Corporation $48.97 3
Karyopharm Therapeutics Inc. $45.49 2
EMD Serono, Inc. $43.42 3
Puma Biotechnology, Inc. $42.14 2
AMAG Pharmaceuticals, Inc. $38.85 2
Taiho Oncology, Inc. $37.75 2
Dova Pharmaceuticals $27.63 2
CHIESI USA, INC. $27.41 2
Regeneron Healthcare Solutions, Inc. $26.32 1
Rigel Pharmaceuticals, Inc. $26.12 2
Sirtex Medical Inc $24.07 2
ARRAY BIOPHARMA INC $20.42 2
Kyowa Kirin, Inc. $20.39 1
Jazz Pharmaceuticals Inc. $18.41 1
Novocure Inc. $15.39 1
Dendreon Pharmaceuticals LLC $14.26 1
Pharmacosmos Therapeutics Inc. $14.22 1
Advanced Accelerator Applications $13.55 1
Agios Pharmaceuticals, Inc. $12.32 1

Page 3 of 7; records 101–150 of 303 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JANET PAN

NPI 1801056676 · CMS profile ID 354136

FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 7; records 101–150 of 303 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1801056676?year=2020&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JANET PAN, NPI 1801056676, CMS profile ID 354136. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 7; records 101–150 of 303 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1801056676?year=2020&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). JANET PAN, NPI 1801056676, CMS profile ID 354136. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 7; records 101–150 of 303 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1801056676?year=2020&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
JANET PAN, NPI 1801056676, CMS profile ID 354136, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 7; records 101–150 of 303 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1801056676?year=2020&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

303 matching records · $5,339.64 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 303 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 303.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Incyte Corporation $14.8009/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 745794591 CMS
Incyte Corporation $1.3709/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 745794599 CMS
Incyte Corporation $3.8309/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 745794595 CMS
Novartis Pharmaceuticals Corporation $15.3409/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726061834 CMS
Incyte Corporation $17.7209/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 745794603 CMS
E.R. Squibb & Sons, L.L.C. $12.4409/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727809611 CMS
Merck Sharp & Dohme Corporation $19.5409/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747759333 CMS
Janssen Biotech, Inc. $12.5909/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719189601 CMS
Bayer HealthCare Pharmaceuticals Inc. $23.7309/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 713636573 CMS
Foundation Medicine, Inc. $27.2209/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 714557511 CMS
Amgen Inc. $20.2509/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741108967 CMS
Eisai Inc. $22.8708/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751220371 CMS
Seagen Inc. $17.6208/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 732438569 CMS
E.R. Squibb & Sons, L.L.C. $14.1308/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727809595 CMS
AstraZeneca Pharmaceuticals LP $16.3108/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735881251 CMS
Seagen Inc. $24.5308/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 732438531 CMS
Astellas Pharma US Inc $10.0008/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 718365319 CMS
Janssen Biotech, Inc. $20.1608/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719189615 CMS
Novartis Pharmaceuticals Corporation $21.8408/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726061829 CMS
AstraZeneca Pharmaceuticals LP $12.1308/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736391955 CMS
Foundation Medicine, Inc. $26.6308/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 714557509 CMS
E.R. Squibb & Sons, L.L.C. $15.8708/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727809607 CMS
Pharmacyclics LLC, An AbbVie Company $22.6208/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725668309 CMS
AbbVie Inc. $16.7908/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722064903 CMS
Janssen Biotech, Inc. $18.7008/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719189605 CMS
Eisai Inc. $23.5208/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751217337 CMS
AstraZeneca Pharmaceuticals LP $30.0808/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736145227 CMS
Alexion Pharmaceuticals, Inc. $26.7508/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726620527 CMS
Rigel Pharmaceuticals, Inc. $11.5708/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752093329 CMS
Bayer HealthCare Pharmaceuticals Inc. $7.9408/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 713621859 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.7308/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720879467 CMS
GlaxoSmithKline, LLC. $20.9108/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738771073 CMS
Pharmacyclics LLC, An AbbVie Company $29.0608/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725670115 CMS
E.R. Squibb & Sons, L.L.C. $16.6908/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727809597 CMS
Dendreon Pharmaceuticals LLC $14.2607/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749838857 CMS
Novartis Pharmaceuticals Corporation $20.2207/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726061825 CMS
Amgen Inc. $10.3107/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741108963 CMS
CHIESI USA, INC. $14.5407/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751489945 CMS
Amgen Inc. $15.6607/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741108957 CMS
Amgen Inc. $15.6607/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741108959 CMS
PFIZER INC. $16.7107/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743353745 CMS
Amgen Inc. $19.7807/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741397125 CMS
Teva Pharmaceuticals USA, Inc. $20.5007/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749511801 CMS
AstraZeneca Pharmaceuticals LP $16.5207/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736329567 CMS
AstraZeneca Pharmaceuticals LP $11.1607/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736091281 CMS
Eisai Inc. $18.8807/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751212805 CMS
AstraZeneca Pharmaceuticals LP $16.9407/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736173499 CMS
Dova Pharmaceuticals $14.8807/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752353137 CMS
Foundation Medicine, Inc. $12.5707/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 714557507 CMS
Merck Sharp & Dohme Corporation $23.6607/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747661451 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,304.61 322
PY2020 $5,339.64 303
PY2021 $6,218.12 325
PY2022 $6,396.31 346
PY2023 $6,939.00 351
PY2024 $7,888.97 348
PY2025 $8,105.08 333

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $96,505.50 3
PY2024 Principal investigator $13,150.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $14,535.50 11/20/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1235996173
Principal investigator 1 Celgene Corporation $55,585.00 06/25/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1222306877
Principal investigator 1 Celgene Corporation $26,385.00 04/23/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1222306937